The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
出版年份 2016 全文链接
标题
The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 81, Issue 5, Pages 878-890
出版商
Wiley
发表日期
2015-12-12
DOI
10.1111/bcp.12861
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
- (2015) Robert Baranello et al. Current Alzheimer Research
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- The dark sides of amyloid in Alzheimer's disease pathogenesis
- (2014) Pierpaolo Sorrentino et al. FEBS LETTERS
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
- (2014) Orly Vardeny et al. JACC-Heart Failure
- Fluid biomarkers in Alzheimer’s disease – current concepts
- (2013) Christoffer Rosén et al. Molecular Neurodegeneration
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Increased in Vivo Amyloid- 42 Production, Exchange, and Loss in Presenilin Mutation Carriers
- (2013) R. Potter et al. Science Translational Medicine
- Proteolytic Degradation of Amyloid -Protein
- (2013) T. Saido et al. Cold Spring Harbor Perspectives in Medicine
- Trafficking and Proteolytic Processing of APP
- (2013) C. Haass et al. Cold Spring Harbor Perspectives in Medicine
- APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38
- (2012) Maria Luisa Moro et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-β Peptide Pool
- (2012) Annelies Vandersteen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Amyloid-β forms fibrils by nucleated conformational conversion of oligomers
- (2011) Jiyong Lee et al. Nature Chemical Biology
- CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies
- (2010) E. Mulugeta et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- -Secretase-dependent amyloid- is increased in Niemann-Pick type C: A cross-sectional study
- (2010) N. Mattsson et al. NEUROLOGY
- Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin
- (2008) Vicki Betts et al. NEUROBIOLOGY OF DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started